Merck to invest $1 billion in U.S. drug manufacturing plant
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.
Merck
Moderna announces test results for skin cancer vaccine
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
Merck sues government over Medicare drug pricing, claiming "extortion"
Drugmaker says it's unconstitutional for the feds to negotiate drug prices on behalf of seniors. Patient advocates say it's "desperately needed."
Drug companies report progress on potential skin cancer vaccine
Moderna's stock soared after the COVID-19 vaccine maker detailed progress in developing a potential preventive shot for melanoma, a deadly form of skin cancer.
10/11: CBSN AM
Merck seeks emergency approval for COVID-19 pill; Missing boy in Texas found alive after desperate search
Concerns mount over COVID vaccination rates
The rate of coronavirus vaccinations in the U.S. continues to slow down. This comes as President Biden's goal to get at least 70% of Americans partially vaccinated by July 4 looms. CBS News reporter Alex Tin joins CBSN's "Red & Blue" with the latest updates on the COVID pandemic.
New oral COVID treatment shows promising results
A new study shows an oral COVID-19 treatment from Merck reduces the risk of hospitalization and death. CBS News medical contributor, Dr. David Agus joins “CBS Mornings” to discuss.
U.S. COVID cases surge ahead of holidays
New cases of the Omicron variant are spreading rapidly in the U.S. ahead of the holidays. People are dealing with long lines at testing sites across the nation. At-home testing kits are also short in supply and pharmacies are limiting how many customers can buy. CBS News correspondent Nancy Chen reports from New York City. Then critical care physician Dr. Lakshmana Swamy joins CBSN's Debra Alfarone to discuss the latest on the pandemic.
FDA approves second COVID treatment pill
The FDA has authorized the second antiviral pill to treat COVID-19. CBS News' Michael George reports. Then Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital at Harvard Medical School, joins CBSN to break down how the drugs work. He also explains why he thinks the CDC should implement "circuit breakers," short-term restrictions on high-risk activities to help curb the spread of the Omicron variant.
Omicron spike collides with holiday travel surge
The FDA authorized the first pill to treat COVID-19. The milestone comes as U.S. cases, hospitalizations and deaths are all rising, with health officials warning of a possible tsunami of new Omicron cases that could overwhelm hospitals. Nancy Chen has the details.
FDA's advisory committee backs Merck's COVID pill
The U.S. may soon be implementing new testing requirements for travelers entering the U.S. amid growing concerns over the new COVID Omicron variant. This week a panel of FDA advisers voted to endorse Merck’s COVID-19 antiviral pill for high-risk individuals. Infectious diseases physician at Brigham and Women's Hospital and chair of that FDA panel, Dr. Lindsey Baden, joins CBSN AM to discuss.
FDA advisers endorse Merck's COVID antiviral drug in narrow vote
The vote paves the way for the agency to authorize molnupiravir for emergency use in American adults.
Pfizer says COVID pill reduces severe illness
Pfizer says its antiviral COVID-19 pill is 89% effective at prevent hospitalizations and 100% effective against deaths from the virus if taken within three days of a person experiencing symptoms. Dr. John Moore, professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero to discuss the potentially life-saving drug.
Doctor on COVID antiviral pills and vaccines
Pfizer and Merck have both developed antiviral pills that could help reduce the risk of hospitalization or death from COVID-19. Dr. Giridar Malyah, senior policy officer at the Robert Wood Johnson Foundation, joins CBSN to discuss the latest on the coronavirus pandemic.
COVID antiviral pill approved in the U.K.
A new antiviral drug that is taken orally to treat COVID-19 has been authorized by medical officials in the U.K. The pill from Merck is for people with mild to moderate symptoms or those considered "high risk." CBS News foreign correspondent Imtiaz Tyab joins CBSN anchors Vladimir Duthiers and Anne-Marie Green from London with details.
U.S. COVID-19 infections continue downward trend
Coronavirus infections in the U.S. are declining from their latest peak but experts warn of a possible rough winter ahead. CBS News correspondent Manuel Bojorquez has the day's coronavirus headlines. Then Dr. Andrew Bazemore, a family medicine physician and the senior vice president of research and policy at the American Board of Family Medicine, joins CBSN"s Elaine Quijano to discuss the latest.
Merck seeks FDA authorization for COVID pill
Drugmaker Merck is asking the FDA for an emergency use authorization for an oral pill to treat COVID-19. Manuel Bojorquez reports.
Merck asks FDA to authorize first pill to treat COVID-19
The giant drugmaker is seeking the emergency authorization for molnupiravir, which it says cut hospitalizations and deaths by half among patients with early COVID-19 symptoms.
Merck seeks FDA authorization for COVID pill
Merck has asked the FDA for emergency authorization for what would be the first pill to treat COVID-19. CBS News' Skyler Henry reports on the latest. Then Dr. Eric Cioe-Pena, director of global health at Northwell Health, joined CBSN's Tanya Rivero to discuss that plus the timeline on vaccines for kids.
Study: COVID pill cuts deaths in half
Pharmaceutical company Merck says its experimental pill significantly reduces the effects of COVID-19 and plans to submit its findings to the Food and Drug Administration for emergency use authorization. CBS News researcher Max Bayer speaks with CBSN's Tanya Rivero about how this drug differs from those already in use.
Doctor on COVID treatment, rural death toll
Merck says clinical trials show its antiviral pill for COVID-19 can reduce hospitalizations and deaths by half in people recently infected with the virus. Meanwhile, new data shows how hard the virus is hitting rural areas of the U.S. Dr. Ali Mokdad, chief strategy officer for Population Health at the University of Washington, joins CBSN to discuss the latest on the pandemic, plus new research in the medical journal The Lancet about deaths at the hands of police.
Merck reports promising results from experimental COVID-19 pill
Company says molnupiravir cut hospitalizations and deaths by half in people recently infected with the virus and it will soon ask authorities to approve the pill's use.
Violence against nurses increases amid pandemic
A new report by National Nurses United finds about 31% of hospital nurses say they have seen an increase in workplace violence. Justin Gill, an urgent care nurse practitioner, health policy lecturer and vice president of the Washington State Nurses Association, joins CBSN to discuss the survey, as well as efforts by Merck to develop an oral antiviral drug to fight COVID-19.
CEO quit Trump council
After the President Trump's response to the violence in Charlottesville, Virginia, the CEOs of Under Armour, Intel, Merck and the Alliance for American Manufacturing stepped down from the Presidential Council on Manufacturing. The president of the AFL-CIO announced Tuesday night he would do so as well. Julianna Goldman reports.
Germany's Bayer plans to buy Merck's consumer care business for $14.2 billion, plus more MoneyWatch headlines
Germany's Bayer plans to buy Merck's consumer care business for $14.2 billion. That includes products from Coppertone, Claritin and Dr. Scholl's. Merck is based in New Jersey. Jill Wagner has that story and more MoneyWatch headlines.
Bank of America CEO warns market "will punish people" without independent Fed
Bank of America Chairman and CEO Brian Moynihan stated last week that, as President Trump seeks a new chair of the Federal Reserve, maintaining the banking system's independence is paramount.
Russia targets Kyiv with deadly strikes ahead of Trump-Zelenskyy meeting
Explosions boomed across Kyiv for hours as ballistic missiles and drones hit the city in an attack that began early in the morning.
Brigitte Bardot, 1960s cinema icon and animal rights activist, dies at 91
At the height of a cinema career that spanned some 28 films and three marriages, Brigitte Bardot came to symbolize a nation bursting out of bourgeois respectability.
Top news headlines of 2025 month-by-month
From political upheavals and gun violence, to the first American-born pope, "Sunday Morning" host Jane Pauley looks back at key events of a transformative year in U.S. history.
Dad uses cell phone data to rescue missing daughter, police say
After a teen didn't return from walking her dog, her dad used cell phone data to find her in a secluded area two miles away.
South Korean mine could soon supply the U.S. with a critical mineral
The Sangdong mine contains millions of tons of tungsten, known as a war metal that can withstand extraordinary temperatures, something the U.S. desperately needs for defense.
Ski patrol strike shuts down Colorado's popular Telluride resort indefinitely
The Telluride Ski Resort in Mountain Village, Colorado, was shuttered Saturday, with no date set for reopening, due to a labor dispute with the ski patrol union over wages.
Gas line explosion shuts down major Southern California freeway
Several lanes of the 5 Freeway were closed and a shelter-in-place order was issued to residents in Castaic, California, after a gas line ruptured on Saturday.
"Hail and farewell": A tribute to those we lost in 2025
"Sunday Morning" looks back at some of the newsworthy men and women who passed away this year – from musicians and storytellers, to activists and statesmen – who touched us with their creativity and humanity.
U.S.
More U.S.
South Korean mine could soon supply the U.S. with a critical mineral
The Sangdong mine contains millions of tons of tungsten, known as a war metal that can withstand extraordinary temperatures, something the U.S. desperately needs for defense.
"Hail and farewell": A tribute to those we lost in 2025
"Sunday Morning" looks back at some of the newsworthy men and women who passed away this year – from musicians and storytellers, to activists and statesmen – who touched us with their creativity and humanity.
Luke Burbank on making realistic New Year's resolutions
Forget about hitting the gym, or signing up for a foreign language app. Luke Burbank resolves to do far better with his New Year's resolutions in 2026 by committing to goals he can actually keep … probably.
The history of the New Year's Eve ball drop
Since 1907, New Yorkers have marked the New Year with the ceremonial dropping of a huge ball in Times Square. Now, a brand-new ball, covered with more than 5,000 handcrafted Waterford Crystal discs, will help ring in 2026.
Top news headlines of 2025 month-by-month
From political upheavals and gun violence, to the first American-born pope, "Sunday Morning" host Jane Pauley looks back at key events of a transformative year in U.S. history.
MoneyWatch
More MoneyWatch
Bank of America CEO warns market "will punish people" without independent Fed
Bank of America Chairman and CEO Brian Moynihan stated last week that, as President Trump seeks a new chair of the Federal Reserve, maintaining the banking system's independence is paramount.
Planning to return unwanted Christmas gifts? You may be charged fees.
Several major retailers are now charging customers to return items even if they are unopened and in perfect condition.
U.S. stocks hover at record highs after the Christmas holiday
Stocks are mostly flat in quiet morning trading on Friday as investors return from the Christmas holiday.
Here's what is open on the day after Christmas, from retailers to banks
With President Trump declaring Dec. 26 a federal holiday, here's what's open and closed on Dec. 26.
5 money moves to make in 2026, according to financial experts
As many Americans head into 2026 with mounting money worries, reviewing your finances now could help put you on firmer footing next year.
Politics
More Politics
Bank of America CEO warns market "will punish people" without independent Fed
Bank of America Chairman and CEO Brian Moynihan stated last week that, as President Trump seeks a new chair of the Federal Reserve, maintaining the banking system's independence is paramount.
Transcript: Bank of America CEO Brian Moynihan on "Face the Nation with Margaret Brennan," Dec. 28, 2025
The following is the transcript of the interview with Bank of America Chairman and CEO Brian Moynihan that aired on "Face the Nation with Margaret Brennan" on Dec. 21, 2025. Editor's note: This interview was filmed on Dec. 17, 2025.
Trump calls for release of any Epstein files naming Democrats: "Embarrass them"
As prosecutors contend with a massive trove of Epstein files, President Trump suggested Friday the Justice Department is spending too much time on the issue — but said Democrats should be named.
Karoline Leavitt announces she is pregnant with her second child
Karoline Leavitt and her husband, Nicholas Riccio, welcomed their first child, also named Nicholas, in July 2024.
Veterans Affairs Department reimposing near total abortion ban
The Veterans Affairs Department is reimposing a near total ban on abortions for veterans and their families that was modified in 2022.
HealthWatch
More HealthWatch
HealthWatch
Flu cases skyrocket across the U.S
Nearly five million flu cases have been reported nationwide, the CDC estimates, and at least 1,900 people have died from the virus. "CBS Saturday Morning" has more on why this year's strain is breaking records.
Baby defies all odds after growing outside his mom's womb
Suze Lopez, a 41-year-old nurse who lives in Bakersfield, California, didn't know she was pregnant with her second child until days before giving birth.
FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
Aetna to cover IVF treatments for same-sex couples in national settlement
A federal judge has approved a preliminary agreement for a class action lawsuit requiring Aetna to cover fertility treatments for same-sex couples as they do with heterosexual couples.
Flu season is ramping up, and some experts are "pretty worried"
Doctors and scientists say this year's influenza season could be tougher than usual, with a new version of the flu virus, called H3N2, spreading quickly.
World
More World
Transcript: Bank of America CEO Brian Moynihan on "Face the Nation with Margaret Brennan," Dec. 28, 2025
The following is the transcript of the interview with Bank of America Chairman and CEO Brian Moynihan that aired on "Face the Nation with Margaret Brennan" on Dec. 21, 2025. Editor's note: This interview was filmed on Dec. 17, 2025.
South Korean mine could soon supply the U.S. with a critical mineral
The Sangdong mine contains millions of tons of tungsten, known as a war metal that can withstand extraordinary temperatures, something the U.S. desperately needs for defense.
1,000-pound U.S.-made WWII bomb found in Belgrade construction site
Unexploded bombs dating back to past wars have been discovered in Serbia and around the world in recent years.
Brigitte Bardot, 1960s cinema icon and animal rights activist, dies at 91
At the height of a cinema career that spanned some 28 films and three marriages, Brigitte Bardot came to symbolize a nation bursting out of bourgeois respectability.
Rescuers search for soccer coach, children after boat sinks in Indonesia
The Spanish soccer club Valencia said that a coach for its women's reserve team, Fernando Martín, and three of his children were among the victims.
Entertainment
More Entertainment
Entertainment
MetroCard art: Swiping beauty from the mundane
On December 31, New York City will officially retire the transit system's MetroCard, that ubiquitous piece of plastic used to gain entrance onto subways and buses. But there is beauty in using MetroCards as the raw materials for art, as Thomas McKean has found in his collages and miniature sculptures depicting portraits of city life. Serena Altschul reports.
2025: The year's top books
"Sunday Morning" checks out the bestselling fiction and non-fiction of the past year.
2025: The year's top movies
"Sunday Morning" checks out the highest-grossing films of the past year.
2025: The year's top music
"Sunday Morning" checks out Spotify's top streaming hits of the past year.
The Book Report: Ron Charles' picks from 2025
The Washington Post book reviewer offers "Sunday Morning" viewers his picks for fiction and non-fiction titles to add to their New Year's reading lists.
Technology
More Technology
Technology
Instacart ending AI price tests for retailers
Instacart says its ending its controversial system of using AI price tests for retailers. Earlier this month, an investigation by Consumer Reports and progressive think tank Groundwork Collaborative found that Instacart's algorithmic pricing charged various prices for the same item from the same store. Jo Ling Kent reports.
Tech companies push for data centers
Massive tech companies wanting to build more data centers in the U.S. are lobbying for support among Americans, according to a recent report by POLITICO. Gabby Miller joins CBS News with more on her reporting.
How AI powered robots are helping small farms
From labor shortages to environmental impacts, farmers are looking to AI to help revolutionize the agriculture industry. One California startup, Farm-ng, is tapping into the power of AI and robotics to perform a wide range of tasks, including seeding, weeding and harvesting.
Top tech gadgets of 2025
Timothy Werth, a tech editor at Mashable, joins "CBS News 24/7" to discuss the best gadgets of 2025.
Instacart to end AI price tests for retailers following investigation
Instacart had drawn criticism for testing an AI-based system that enabled retailers to charge different prices for the same grocery items.
Science
More Science
Major climate research center on Trump administration chopping block
The Trump administration intends to dismantle one of the world's leading climate research institutions, in Boulder, Colorado, over what it said were concerns about "climate alarmism."
Researchers capture video of rare polar bear adoption
The footage of a bear caring for an adopted cub was captured during the annual polar bear migration along the Western Hudson Bay in Churchill, Manitoba.
Dinosaur tracks showing "herds moving in synchrony" found in Italy
Most of the footprints are elongated and made by bipeds. The best-preserved ones bear traces of at least four toes.
Interstellar comet is making its closest approach to Earth
NASA continues to aim its space telescopes at the visiting ice ball, estimated to be up to 3.5 miles in size.
Fossil footprints in Bolivia reveal dinosaurs' awkward attempts to swim
Paleontologists have discovered and documented 16,600 footprints left by theropods, the dinosaur group that includes the Tyrannosaurus rex.
Crime
More Crime
Man says wife was killed by pipe coming through car windshield
Todd Kendhammer said his wife Barbara was killed in a freak accident, but a Wisconsin jury didn't believe him. Can his new attorneys upend the case with what they say is critical new evidence?
Man charged with fatal shooting of woman during backyard target practice
The victim was sitting with her family under a covered porch several blocks away when she was hit by a bullet, according to a probable cause affidavit.
Dad uses cellphone data to rescue missing daughter, police say
After a teen didn't return from walking her dog, her dad used cellphone data to find her in a secluded area two miles away.
What's next on the Epstein files release?
Lawmakers may take action against the Department of Justice for the delayed release of the Jeffrey Epstein files. CBS News legal contributor Jessica Levinson weighs in.
Two police officers injured, suspect killed during child custody exchange
Police were called to a shopping center late Friday morning. Two officers were shot and are in critical condition.
Space
More Space
Space
NASA's search for next lunar rover
NASA astronauts took their first drive on the moon 54 years ago. Now, three companies are competing for a NASA contract to build a new lunar rover for use starting with the Artemis 5 mission in 2030. Kris Van Cleave reports.
Artemis 2 astronauts rehearse countdown for upcoming moon launch
NASA is gearing up to send four Artemis astronauts on looping test flight around the moon in 2026.
Woman is first wheelchair user launched into space
A German aerospace engineer made history Saturday, becoming the first wheelchair user to go into space when she took a 10-minute trip aboard a Blue Origin rocket.
Blue Origin safely launches wheelchair user to space and back
German engineer Michaela Benthaus is the first person with a significant physical handicap to reach space.
Jared Isaacman, billionaire who's flown with SpaceX, confirmed to lead NASA
President Trump withdrew Isaacman's nomination for NASA administrator in April, before nominating him again in November.
Latest Galleries
More Latest Galleries
Notable Deaths in 2025
A look back at the esteemed personalities who've left us this year, who'd touched us with their innovation, creativity and humanity.
Evidence in the Barbara Kendhammer case
Does the evidence show a cover-up, or was Todd Kendhammer wrongfully convicted for the murder of his wife?
The life & near death of prizefighter Christy Salters-Martin
Christy Salters-Martin dominated in the boxing ring but faced her toughest challenger at home.
Timeline: The disappearance of George Smith
Family seeks answers in death of newlywed who disappeared in 2005 while on Mediterranean honeymoon cruise.
Who is Alix Tichelman?
Meet the tattooed beauty charged in the death of Google executive Forrest Hayes.
Latest CBS News Videos
More Latest CBS News Videos
Latest CBS News Videos
Moynihan on new Fed chair
Bank of America CEO Brian Moynihan talks prices, affordability, inflation predictions for 2026, the "shock" from the business community when President Trump enacted tariffs and how "the market will punish people if we don't have an independent Fed." Editor's note: This interview was filmed on Dec. 17, 2025.
Open: "Face the Nation," Dec. 28, 2025
This week on "Face the Nation with Margaret Brennan," a look back on 2025, a year filled with change that's turned Washington norms upside down -- and a year filled with news of great tragedy, but also moments of true triumph. Plus, our correspondents' predictions for 2026.
Nature: Sunrise in Texas
We leave you this last Sunday of 2025 with sunrise at the Great Trinity Forest in Dallas, Texas. Videographer: Scot Miller.
CBS News correspondents' panel
Major Garrett, Robert Costa, Jan Crawford, Jennifer Jacobs and Scott MacFarlane join Margaret Brennan to discuss the biggest stories of 2025 and share their predictions for 2026. Editor's note: This segment was filmed on Dec. 21, 2025.
2025: The year in photos
"Sunday Morning" looks back at some of the most memorable news images of the past year.